MYRAPHIDAN LIMITED

Company Registration Number:
15542509 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2025

Period of accounts

Start date: 06 March 2024

End date: 31 March 2025

MYRAPHIDAN LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2025

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8

MYRAPHIDAN LIMITED

Company Information

for the Period Ended 31 March 2025




Director: Raphael Daniel
Registered office: 38 Gunning Place
Callender Road
Erith
England
DA8 3FD
Company Registration Number: 15542509 (England and Wales)

MYRAPHIDAN LIMITED

Directors' Report Period Ended 31 March 2025

The directors present their report with the financial statements of the company for the period ended 31 March 2025

Directors

The director(s) shown below were appointed to the company during the period
Raphael Daniel
06 March 2024

This report was approved by the board of directors on 21 October 2025
And Signed On Behalf Of The Board By:

Name: Raphael Daniel
Status: Director

MYRAPHIDAN LIMITED

Profit and Loss Account

for the Period Ended 31 March 2025


Notes
13 months to
31 Mar 2025
£
Gross Profit or (Loss) 20
Administrative Expenses ( 650 )
Operating Profit or (Loss) ( 630 )
Profit or (Loss) Before Tax ( 630 )
Profit or (Loss) for Period ( 630 )

The notes form part of these financial statements

MYRAPHIDAN LIMITED

Balance sheet

As at 31 March 2025


Notes
13 months to
31 Mar 2025
£
Fixed assets
Total fixed assets: -
Current assets
Creditors: amounts falling due after more than one year: ( 650 )
Total net assets (liabilities): ( 650 )

The notes form part of these financial statements

MYRAPHIDAN LIMITED

Balance sheet continued

As at 31 March 2025


Notes
13 months to
31 Mar 2025
£
Capital and reserves
Called up share capital: 1
Profit and loss account: ( 651 )
Shareholders funds: ( 650 )

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 21 October 2025
And Signed On Behalf Of The Board By:

Name: Raphael Daniel
Status: Director

The notes form part of these financial statements

MYRAPHIDAN LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

MYRAPHIDAN LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 2. Employees

    13 months to
    31 Mar 2025
    Average number of employees during the period 0

MYRAPHIDAN LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 3. Off balance sheet disclosure

    No